Awareness of and Attitudes toward Human Papillomavirus Vaccination among Adults in Korea: 9-Year Changes in Nationwide Surveys

Jin-Kyoung Oh; Bo Yoon Jeong; E Hwa Yun; Min Kyung Lim

doi:10.4143/crt.2017.174

Articles

Page Path: HOME > Cancer Res Treat > Volume 50(2); 2018 > Article

Original Article Awareness of and Attitudes toward Human Papillomavirus Vaccination among Adults in Korea: 9-Year Changes in Nationwide Surveys: Jin-Kyoung Oh, PhD^1,2, Bo Yoon Jeong, PhD², E Hwa Yun, PhD^1,2, Min Kyung Lim, PhD^1,2,; Cancer Research and Treatment : Official Journal of Korean Cancer Association 2018;50(2):436-444.
DOI: https://doi.org/10.4143/crt.2017.174
Published online: May 10, 2017

¹Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea

²Cancer Risk Appraisal & Prevention Branch, National Cancer Center, Goyang, Korea

Correspondence: Min Kyung Lim, PhD Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy and Cancer Risk Appraisal & Prevention Branch, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea
Tel: 82-31-920-2016 Fax: 82-31-920-2929 E-mail: mickey@ncc.re.kr

• Received: April 11, 2017 • Accepted: May 6, 2017

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

8,916 Views
234 Download
16 Web of Science
17 Crossref
18 Scopus

prev next

Full Article

Download PDF

Abstract

Purpose
Human papillomavirus (HPV) vaccination has been included in the National Immunization Program in Korea since 2016. We aimed to evaluate changes in the awareness of and attitudes toward HPV vaccination, among adults in Korea since the first introduction of the vaccines in 2007.
Materials and Methods
A nationwide population-based survey was conducted in 2016 for 1,200 nationally representative Korean men and women; the data obtained were compared with the data from the nationwide survey conducted in 2007.
Results
A significant increase in the awareness of HPV infection (35.8%) and vaccination (36.9%) was observed in 2016 from 13.3% and 8.6% in 2007, respectively. Willingness to be vaccinated against HPV decreased from 55.0% in 2007 to 25.8% in 2016, and the proportion of respondents expressing uncertainty increased from 28.3% in 2007 to 43.3% in 2016. Only 12.1% of men and 22.0% of women knew about the free national HPV vaccination program for girls, launched in June 2016. Younger women, with higher income level, awareness of the HPV vaccine, and perception of the seriousness of infections had a higher willingness to be vaccinated. A high education level, awareness of HPV infection and vaccination, and perception of the seriousness of infection were positively associated with the willingness of respondents to vaccinate their daughters.
Conclusion
Raising the awareness of HPV infection and vaccination with appropriate knowledge is necessary for the successful implementation of the national HPV vaccination program.
Key words: Human papillomavirus, Vaccination, Awareness, Korea

Introduction

The prophylactic human papillomavirus (HPV) vaccine is a key component in cervical cancer control. The World Health Organization recommends the inclusion of HPV vaccines in national immunization programs [1]. Since 2007 and 2008, quadrivalent and bivalent HPV vaccines have been approved for use in South Korea. However, there had been no national or governmental HPV vaccination program, such as organized school-based vaccination or subsidized vaccination programs, until 2016. Thus, the vaccine coverage during this period was low (12% among adult women [2]; 1%-10% among high school girls [3-6]). Moreover, awareness regarding HPV vaccination and its effectiveness, which is an important factor that influences the voluntary reception of the vaccination, was low among adult men and women [7], mothers [5,8], high-school girls [3,4], and college students [9,10].

Since June 2016, HPV vaccination has been included in the fully funded National Immunization Program in Korea. The quadrivalent and bivalent HPV vaccines have also been included in the National HPV vaccination program, to be administered in 2 doses, to 12-year-old girls [11]. Furthermore, as one of the “10 codes for cancer prevention in Korea,” HPV vaccination has been recommended for cervical cancer prevention at the national level. The successful introduction and acceptance of the vaccine depends on a range of factors, including the awareness of the importance of HPV infection in cervical cancer, awareness of the use of vaccination as a preventive method, affordability of the vaccine, acceptability of the vaccine among groups, and the feasibility of delivery strategies [12].

Thus, assessing the level of awareness regarding the importance of HPV infection and vaccination among adults in Korea is necessary to predict the success of the national HPV vaccination program, as well as to measure the impact of previous educational campaigns. Therefore, we analyzed and compared data from nationwide population-based interview surveys conducted in 2007, when the HPV vaccination was introduced in Korea, and in 2016, when the HPV vaccination was included in the national routine vaccination program.

Materials and Methods

The first survey on the awareness of the HPV vaccination was conducted in November 2007 and the main results have been previously published [7]. Briefly, 1,000 randomly selected men and women over the age of 20 years in 15 of the 16 provinces in Korea responded to a face-to-face interview survey performed by trained interviewers, using a structured questionnaire. The second survey was conducted between July 5, 2016, and August 4, 2016, and involved 1,200 randomly selected men and women over the age of 20 years in the 16 provinces. The target households were randomly sampled from each district, considering the total population number, as well as the age and sex distribution in each district and province.

The second survey employed the same questionnaire used in the first survey. Participants were asked about their awareness of HPV infections, as a primary cause of cervical cancer, and their awareness of the prevention of cervical cancer via HPV vaccination. To understand the subjects’ attitudes toward HPV vaccination, questions focused on five concepts were adapted from the Health Belief Model: perceived susceptibility to HPV infection, perceived severity of HPV infection, perceived benefits of HPV vaccination, perceived barriers to HPV vaccination, and cues to action for HPV vaccination [13]. Questions on the perceived benefits included the respondent’s willingness to vaccinate themselves and their children against HPV. A second questionnaire was added to the survey, regarding the awareness of the national HPV vaccination program, targeting 12-year-old girls that commenced in June 2016. General demographic characteristics including age, sex, place of residence, level of education, occupation, and family income were also collected.

Categorical variables are presented as numbers or percentages, and differences in distributions were evaluated using the Cochrane Mantel-Haenszel chi-square test with adjustment for age group. Logistic regression analysis was used to evaluate the association between the acceptance of the HPV vaccination, and related factors such as age (20-29, 30-39, 40-49, and 50 years or older), sex, residence (metropolitan area, city, and country), education (primary school or less, middle school, high school, and college or more), and family income (“low” for family incomes less than 2,000 US dollars, “middle” for incomes between 2,000 and 4,000 US dollars, and “high” for incomes greater than 4,000 US dollars); the odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. All analyses were performed using SAS ver. 9.3 (SAS Institute Inc., Cary, NC).

This study was approved by the ethics committee of the National Cancer Center in Korea (IRB Nos. NCCNCS-07-102, NCC2016-0153).

Results

Table 1 shows the general characteristics of the respondents. The sex and regional distributions were similar in the 2007 and 2016 surveys. The respondents in the 2016 survey were more likely to be older, have higher education, and be an office worker compared to the respondents in the 2007 survey, reflecting an aging population.

Table 2 shows the differences in awareness of and attitudes regarding HPV infection and vaccination between the 2007 and 2016 surveys. The awareness of the importance of HPV infection (35.8% in 2016) and vaccination (36.9% in 2016) were significantly increased from that in 2007 (13.3% and 8.6%, respectively) (p < 0.001). The proportion of respondents who reported being invulnerable to HPV infection increased from 28.2% in 2007, to 42.0% in 2016. On the other hand, the proportion of respondents who reported being unsure of their vulnerability (52.3% in 2007, 37.3% in 2016) had decreased since 2007. The proportion of respondents who considered HPV infection as non-serious had increased from 8.0% to 23.7% since 2007, whereas the proportion of respondents who were uncertain about the seriousness of HPV had decreased from 59.5% to 37.3% since 2007. In addition, the willingness to be vaccinated against HPV decreased from 55.0% in 2007 to 25.8% in 2016; the proportion of those who responded with uncertainty increased from 28.3% in 2007 to 43.3% in 2016. The most common reason for refusal of vaccination was the unimportance attached to its practice (47%), followed by the lack of its awareness (32.7%), high cost (13.7%), uncertainty about its effectiveness (11.4%), and subsequent adverse reactions (9.9%). In addition, the willingness of some respondents to vaccinate their daughters (77.0% in 2007, 69.5% in 2016) and sons (73.2% in 2007, 58.3% in 2016) had decreased over the years. Among respondents who were willing, 2.7% and 0.8% had already vaccinated their daughters or sons, respectively. Only 12.1% of men and 22.0% of women knew about the free national HPV vaccination program for girls launched in June 2016.

Table 3 shows the factors associated with the willingness of respondents to vaccinate themselves and their daughters, in the 2016 survey. In women, a higher willingness to be vaccinated was associated with younger age, higher income level, awareness of the HPV vaccine (adjusted OR, 1.3; 95% CI, 1.0 to 1.8), and perception of the seriousness of infection (adjusted OR, 2.4; 95% CI, 1.6 to 3.4). In addition, a high level of education, awareness of the importance of HPV infection (OR, 1.5; 95% CI, 1.2 to 2.0), awareness of the vaccination (OR, 1.7; 95% CI, 1.3 to 2.2), and perception of the seriousness of infection (OR, 2.5; 95% CI, 1.8 to 3.4) were positively associated with the respondents’ willingness to vaccinate their daughters. Furthermore, women (adjusted OR, 1.5; 95% CI, 1.1 to 1.9) had a higher willingness to vaccinate their daughters compared to men.

Additionally, only 17% of the respondents (12.1% of men, 22.0% of women) knew about the national HPV vaccination program launched in June 2016. Women (OR, 2.3; 95% CI, 1.7 to 3.1) and respondents aged 40-49 years (OR, 1.8; 95% CI, 1.2 to 2.7) with a high level of education (OR, 4.3; 95% CI, 1.5 to 12.5 in the level of college or more compared to the level of middle school or less), awareness of HPV infection as a risk factor for cervical cancer (OR, 2.3; 95% CI, 1.7 to 3.2), and awareness of the vaccination (OR, 3.5; 95% CI, 2.5 to 4.9) were more likely to know about the National HPV Vaccination Program (Table 4).

Discussion

The incidence and mortality rates for cervical cancer have been decreasing steadily (age-standardized incidence rate, 16.3 per 100,000 women in 1999 and 9.5 in 2013; 5-year relative survival rate, 77.5% in 1993-1995 and 80.1% in 2009-2013 [14]), partly due to organized cervical cancer screenings [15]. However, cervical cancer is still one of the 10 major female cancers in Korea. In 2014, 3,500 new cases were diagnosed and 967 women died from cervical cancer [16].

As well known, cervical cancer can be avoided through the prevention of HPV infections. Therefore, since 2007, safe sexual behavior has been promoted as one of the 10 codes for cancer prevention in Korea, thereby, preventing cervical cancer development via the prevention of the sexual transmission of an HPV infection. Within the same period, HPV vaccines were introduced and used in Korea, but without an organized immunization program. Thus, vaccine coverage was low due to a lack of awareness of the HPV infection and vaccination, as well as the cost of vaccination [7]. Subsequently, the promotion of HPV vaccination by the private sector decreased the cost of vaccination; however, this did not substantially increase vaccine coverage. According to the Korean National Immunization Survey, vaccination coverage in 2013 was 28.7%, 15.9%, and 4.6% among women aged 19-26 years, 27-39 years, and 40-59 years, respectively [2]. Although there is no national data on vaccine coverage in young girls, several studies have demonstrated low rates among high school girls (1%-10%) [3-6]. Given that HPV is a cause of cervical cancer, and a safe and effective vaccine is available, the most effective target population is young girls without any sexual experience. Thus, in 2016, the Korean government, as a part of the National Immunization Program, offered a fully funded HPV vaccination opportunity to girls aged 12 years [11]. Therefore, it is very important to assess the awareness of the HPV infection and vaccination in the general population, which are possible key factors affecting the acceptance of HPV vaccination.

The results of the present study demonstrate that among adults, the awareness of HPV infection as a risk factor for cervical cancer has increased since 2007. In addition, the awareness of HPV vaccination as a preventive measure for cervical cancer has increased since 2007, while the willingness of respondents to vaccinate themselves or their daughter(s) against HPV has decreased since 2007 [7]. One possible explanation for these findings is that an awareness has been raised by the government sector, through the dissemination of information regarding the modes of acquisition of the HPV infection, as well as the promotion of HPV testing and vaccination in the private sectors. Furthermore, available information on HPV-related issues has improved knowledge; this has reduced uncertainty and misconceptions. Among adults, correct knowledge and an improved awareness of the HPV vaccination may decrease willingness to vaccinate themselves against HPV. Many sources, including the National Cancer Information Center (http://www.cancer.go.kr) and the Centers for Disease Control & Prevention (http://nip.cdc.go.kr), continually provide reliable detailed information regarding HPV infections, cervical cancer, and the HPV vaccine. The information emphasizes the higher effectiveness of the HPV vaccine in young girls compared to middle-aged women and men. The most common reason for refusal of the HPV vaccination in the present study was the perception of some respondents that the vaccine was not necessary for them. However, men and women with a higher educational level, greater knowledge regarding HPV infection and vaccination, and greater perception of the seriousness of HPV infections had a high willingness for vaccination and were more likely to vaccinate their daughter(s) against HPV.

The results of the present study demonstrate that the overall awareness of the national HPV vaccination program is still very low; however, the awareness of the newly launched national HPV vaccination program was relatively higher in women with high educational level, and awareness of HPV infection and vaccination. Respondents aged 40-49 years reflect an age group with a high probability of having young daughters around 12 years; these were also more likely to know about the national HPV vaccination program, compared to respondents in other age groups. Other evaluated factors did not have a significant effect on the awareness of the national HPV vaccination program. To encourage HPV vaccination among young girls around 12 years of age, it appears to be necessary for the parents of these girls to receive more information regarding the national HPV vaccination program, including why a high priority is placed on this target population, for HPV vaccination, with regard to cervical cancer prevention.

A strength of this study is that data from two nationwide surveys with the same design were used, allowing easy observation of changes in awareness and acceptance of the HPV vaccination over time. The present study also has several limitations. First, the relatively small sample sizes (1,000-1,200 respondents) are not adequate to be representative of the general population in Korea. However, we randomly sampled respondents proportional to size of the population, from 16 provinces (15 provinces in 2007) across the country, who reflected the age and sex distribution in each district and province. As a result, the general characteristics of the respondents are similar to those of the Korean general population. Second, the present study did not include children or adolescents, even though they are the targeted group for HPV vaccination. Further studies on awareness and acceptance of HPV vaccination among various groups including adolescents, parents, teachers, and health professionals are needed.

In conclusion, raising the awareness of HPV infection and vaccination with the appropriate knowledge is necessary for the successful implementation of the national HPV vaccination program. Further promotion and awareness of the national HPV vaccination program could be expected to increase the vaccine coverage, which may guarantee a cervical-cancer-free generation in the future of Korea.

NOTES

Conflict of interest relevant to this article was not reported.

Acknowledgements

This study was financially supported by the Ministry of Health and Welfare (1660660) and partly supported by the National Cancer Center (NCC-1610410).

Table 1.

General characteristics of the respondents in the 2007 and 2016 surveys

Characteristic	Survey year
Characteristic	2007	2016
Sex
Men	496 (49.6)	594 (49.5)
Women	504 (50.4)	606 (50.5)
Age (yr)
20-29	222 (22.2)	196 (16.3)
30-39	239 (23.9)	243 (20.3)
40-49	225 (22.5)	268 (22.3)
≥ 50	314 (31.4)	493 (41.1)
Education
Middle school or less	195 (19.5)	76 (6.3)
High school	459 (45.9)	502 (41.8)
College or more	345 (34.5)	622 (51.8)
Occupation
Agriculture/Forestry/Fishery	39 (3.9)	3 (0.3)
Self-employment	217 (21.7)	152 (12.7)
Clerk/Sale	117 (11.7)	205 (17.1)
Engineer/Driver	57 (5.7)	74 (6.2)
Janitor/Cleaner/Construction worker	20 (2.0)	27 (2.2)
Office worker	141 (14.1)	325 (27.1)
Professional/Manager	9 (0.9)	32 (2.7)
House wife	274 (27.4)	279 (23.2)
Student	68 (6.8)	64 (5.3)
Unemployment	58 (5.8)	39 (3.2)
Household income per month^a)
Low	232 (23.2)	236 (19.7)
Middle	562 (56.2)	685 (57.1)
High	197 (19.7)	279 (23.2)
Region
Metropolitan area	479 (47.9)	542 (45.2)
City	421 (42.1)	523 (43.6)
Country	100 (10.0)	135 (11.2)

Values are presented as number (%).

^a) Income categorized in low (< 2,000 USD), middle (2,000-4,000 USD), and high (> 4,000 USD) in 2007; low (< 3,000 USD), middle (3,000-5,000 USD), and high (> 5,000 USD) in 2016; 1 US dollar=1,000 Korean won.

Table 2.

Awareness of and attitudes toward HPV infection and vaccination: the 2007 and 2016 surveys

Variable	Overall		p-value^a)	Men		p-value^a)	Women		p-value^a)
Variable	2007	2016	p-value^a)	2007	2016	p-value^a)	2007	2016	p-value^a)
[Awareness] Did you know that cervical cancer is related to HPV infection?
No	867 (86.7)	770 (64.2)		459 (92.5)	424 (71.4)		408 (80.9)	346 (57.1)
Yes	133 (13.3)	430 (35.8)	< 0.001	37 (7.5)	170 (28.6)	< 0.001	96 (19.1)	260 (42.9)	< 0.001
[Awareness] Did you know that cervical cancer can be prevented by HPV vaccination?
No	914 (91.4)	757 (63.1)		471 (95.0)	431 (72.6)		443 (87.9)	326 (53.8)
Yes	86 (8.6)	443 (36.9)	< 0.001	25 (5.0)	163 (27.4)	< 0.001	61 (12.1)	280 (46.2)	< 0.001
[Perceived susceptibility] Do you think you can be easily infected with HPV?
No	282 (28.2)	504 (42.0)		149 (30.0)	263 (44.3)		133 (26.4)	241 (39.8)
Yes	195 (19.5)	308 (25.7)		86 (17.3)	98 (16.5)		109 (21.6)	210 (34.6)
Do not know	523 (52.3)	388 (32.3)	< 0.001	261 (52.6)	233 (39.2)	< 0.001	262 (52.0)	155 (25.6)	< 0.001
[Perceived seriousness] Do you think HPV infection is a serious disease?
No	80 (8.0)	284 (23.7)		40 (8.1)	148 (24.9)		40 (7.9)	136 (22.4)
Yes	325 (32.5)	469 (39.1)		126 (25.4)	193 (32.5)		199 (39.5)	276 (45.5)
Do not know	595 (59.5)	447 (37.3)	< 0.001	330 (66.5)	253 (42.6)	< 0.001	265 (52.6)	194 (32.0)	< 0.001
[Perceived benefits] Would you be vaccinated against HPV if HPV infection is preventable?
No	167 (16.7)	348 (30.9)		71 (14.3)	175 (30.5)		96 (19.0)	173 (31.3)
Yes	550 (55.0)	291 (25.8)		275 (55.4)	144 (25.1)		275 (54.6)	147 (26.6)
Uncertain	283 (28.3)	488 (43.3)	< 0.001	150 (30.2)	255 (44.4)	< 0.001	133 (26.4)	233 (42.1)	< 0.001
[Perceived benefits] If HPV infection is preventable, would you vaccinate your daughter against HPV?
No	46 (4.6)	115 (9.6)		28 (5.6)	58 (9.8)		18 (3.6)	57 (9.4)
Yes	770 (77.0)	834 (69.5)		374 (75.4)	391 (65.8)		396 (78.6)	443 (73.1)
Already vaccinated		32 (2.7)			9 (1.5)			23 (3.8)
Will vaccinated		802 (66.8)			382 (64.3)			420 (69.3)
Uncertain	184 (18.4)	251 (20.9)	< 0.001	94 (19.0)	145 (24.4)	0.001	90 (17.9)	106 (17.5)	0.001
[Perceived benefits] If HPV infection is preventable, would you vaccinate your son against HPV for your future daughter-in-law?
No	56 (5.6)	159 (13.3)		29 (5.8)	79 (13.3)		27 (5.4)	80 (13.2)
Yes	732 (73.2)	702 (58.5)		352 (71.0)	341 (57.4)		380 (75.4)	361 (59.6)
Already vaccinated		10 (0.8)			4 (0.7)			6 (1.0)
Will vaccinated		692 (57.7)			337 (56.7)			355 (58.6)
Uncertain	212 (21.2)	339 (28.3)	< 0.001	115 (23.2)	174 (29.3)	< 0.001	97 (19.2)	165 (27.2)	< 0.001
[Awareness] Did you know that free HPV vaccination is available for girls ages 11-12 by a national immunization program in 2016?
No		995 (82.9)			522 (87.9)			473 (78.0)
Yes		205 (17.1)			72 (12.1)			133 (22.0)

Values are presented as number (%). HPV, human papillomavirus.

^a) Cochran-Mantel-Haenszel chi-square test, adjusted for age-group.

Table 3.

Willingness to vaccinate oneself and respondent’s daughter(s) against HPV by selected characteristics, 2016

Characteristic	Total	Willingness to vaccinate oneself^a)			Willingness to vaccinate daughter
		No. (%)	Adjusted OR (95% CI)		No. (%)	Adjusted OR (95% CI)
		No. (%)	Model 1^b)	Model 2^c)	No. (%)	Model 1^b)	Model 2^c)
Sex
Men	594	144 (25.1)	1	1	391 (65.8)	1	1
Women	606	147 (26.6)	1.1 (0.9-1.5)	1.1 (0.9-1.5)	443 (73.1)	1.4 (1.1-1.8)	1.5 (1.1-1.9)
Age (yr)
≥ 50	493	101 (21.3)	1	1	342 (69.4)	1	1
40-49	268	70 (27.8)	1.4 (1.0-2.0)	1.4 (1.0-2.0)	189 (70.5)	1.1 (0.8-1.5)	1.0 (0.7-1.4)
30-39	243	65 (29.3)	1.5 (1.1-2.2)	1.5 (1.0-2.2)	170 (70.0)	1.1 (0.8-1.5)	1.0 (0.7-1.4)
20-29	196	55 (30.7)	1.7 (1.1-2.4)	1.6 (1.1-2.5)	133 (67.9)	1.0 (0.7-1.4)	0.9 (0.6-1.3)
			p-trend=0.004	p-trend=0.009		p-trend=0.926	p-trend=0.637
Education
Middle school or less	76	16 (21.1)	1	1	43 (56.6)	1	1
High school	502	119 (25.1)	1.1 (0.6-2.0)	1.1 (0.6-2.0)	363 (72.3)	2.2 (1.3-3.7)	2.2 (1.3-3.7)
College or more	622	156 (27.1)	1.1 (0.6-2.0)	1.1 (0.6-2.0)	428 (68.8)	2.0 (1.2-3.3)	2.0 (1.2-3.3)
			p-trend=0.821	p-trend=0.821		p-trend=0.308	p-trend=0.308
Income per month
Low (< 3,000 USD)	236	46 (20.1)	1	1	160 (67.8)	1	1
Middle (3,000-5,000 USD)	685	168 (26.3)	1.3 (0.9-1.9)	1.4 (0.9-2.0)	469 (68.5)	1.1 (0.8-1.5)	0.9 (0.7-1.3)
High (> 5,000 USD)	279	77 (29.8)	1.6 (1.0-2.4)	1.7 (1.1-2.6)	205 (73.5)	1.3 (0.9-2.0)	1.2 (0.8-1.9)
			p-trend=0.030	p-trend=0.026		p-trend=0.126	p-trend=0.205
Region
Metropolitan area	542	135 (26.5)	1	1	376 (69.4)	1	1
Middle/Small city	523	132 (26.8)	1.0 (0.8-1.3)	1.0 (0.8-1.3)	371 (70.9)	1.1 (0.8-1.4)	1.0 (0.8-1.4)
Small town	135	24 (19.4)	0.7 (0.4-1.1)	0.7 (0.4-1.1)	87 (64.4)	0.8 (0.5-1.2)	0.7 (0.5-1.1)
			p-trend=0.306	p-trend=0.297		p-trend=0.536	p-trend=0.491
Awareness of HPV infection as a risk factor of cervical cancer
No	770	185 (24.4)	1	1	507 (65.8)	1	1
Yes	430	106 (28.7)	1.2 (0.9-1.6)	1.2 (0.9-1.6)	327 (76.1)	1.6 (1.2-2.1)	1.5 (1.2-2.0)
Awareness of HPV vaccine
No	757	173 (23.7)	1	1	493 (65.1)	1	1
Yes	443	118 (29.8)	1.3 (1.0-1.8)	1.3 (1.0-1.8)	341 (77.0)	1.8 (1.3-2.2)	1.7 (1.3-2.2)
Perceived seriousness
No	284	47 (17.5)	1	1	172 (60.6)	1	1
Yes	469	145 (33.6)	2.4 (1.6-3.4)	2.4 (1.6-3.4)	375 (80.0)	2.5 (1.8-3.5)	2.5 (1.8-3.4)
Do not know	447	99 (23.2)	1.4 (1.0-2.1)	1.4 (1.0-2.1)	287 (64.2)	1.2 (0.9-1.6)	1.2 (0.9-1.6)
Awareness on NHPVP
No	995	239 (25.1)	1	1	682 (68.5)	1	1
Yes	205	52 (29.9)	1.2 (0.8-1.7)	1.2 (0.8-1.7)	152 (74.2)	1.2 (0.9-1.8)	1.2 (0.9-1.7)

HPV, human papillomavirus; OR, odds ratio; CI, confidence interval; NHPVP, National HPV Vaccination Program.

^a) The willingness to vaccinate oneself was analyzed except for 73 persons who had already received HPV vaccination before the survey,

^b) Model 1: multiple logistic regression model adjusted for sex and age,

^c) Model 2: multiple logistic regression model adjusted for sex, age, and education, when appropriate.

Table 4.

Awareness of the national HPV vaccination program by selected characteristics, 2016

Characteristic	Total	Awareness of the National HPV Vaccination Program
		No. (%)	Adjusted OR (95% CI)
		No. (%)	Model 1^a)	Model 2^b)
Sex
Men	594	72 (12.1)	1	1
Women	606	133 (21.9)	2.1 (1.6-2.9)	2.3 (1.7-3.1)
Age (yr)
≥ 50	493	61 (12.4)	1	1
40-49	268	58 (21.6)	2.1 (1.4-3.1)	1.8 (1.2-2.7)
30-39	243	47 (19.3)	1.8 (1.2-2.7)	1.4 (0.9-2.2)
20-29	196	39 (19.9)	1.9 (1.2-3.0)	1.4 (0.9-2.3)
			p-trend=0.002	p-trend=0.130
Education
Middle school or less	76	4 (5.3)	1	1
High school	502	74 (14.7)	2.9 (1.0-8.4)	2.9 (1.0-8.4)
College or more	622	127 (20.4)	4.3 (1.5-12.5)	4.3 (1.5-12.5)
			p-trend < 0.001	p-trend < 0.001
Income per month
Low (< 3,000 USD)	236	35 (14.8)	1	1
Middle (3,000-5,000 USD)	685	119 (17.4)	1.1 (0.7-1.7)	0.9 (0.6-1.4)
High (> 5,000 USD)	279	51 (18.3)	1.2 (0.7-1.9)	0.9 (0.5-1.4)
			p-trend=0.422	p-trend=0.720
Region
Metropolitan area	542	81 (14.9)	1	1
Middle/Small city	523	103 (19.7)	1.4 (1.0-2.0)	1.4 (1.0-1.9)
Small town	135	21 (15.6)	1.0 (0.6-1.8)	1.0 (0.6-1.7)
			p-trend=0.226	p-trend=0.324
Awareness of HPV infection as a risk factor of cervical cancer
No	770	90 (11.7)	1	1
Yes	430	115 (26.7)	2.4 (1.7-3.3)	2.3 (1.7-3.2)
Awareness of HPV vaccine
No	757	73 (9.6)	1	1
Yes	443	132 (29.8)	3.6 (2.6-4.9)	3.5 (2.5-4.9)
Perceived seriousness
No	284	44 (15.5)	1	1
Yes	469	101 (21.5)	1.4 (0.9-2.1)	1.4 (0.9-2.0)
Do not know	447	60 (13.4)	0.9 (0.6-1.4)	0.9 (0.6-1.4)

HPV, human papillomavirus; OR, odds ratio; CI, confidence interval.

^a) Model 1: multiple logistic regression model adjusted for sex and age,

^b) Model 2: multiple logistic regression model adjusted for sex, age and education, when appropriate.

REFERENCES

1. Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec. 2014;89:465–91. PubMed
2. Lee SG, Jeon SY, Park O, Kim MY, Yang HI, Park EY. Vaccination coverage of adults aged above 19 years using mixed-mode random digit dialing (RDD) survey. J Korean Soc Matern Child Health. 2015;19:58–70. Article
3. Kang HS, Moneyham L. Attitudes, intentions, and perceived barriers to human papillomavirus vaccination among Korean high school girls and their mothers. Cancer Nurs. 2011;34:202–8. Article PubMed
4. Lee YE, Park JS, Choi EJ. The exact state of female high school students’ knowledge about cervical cancer, human papillomavirus vaccination-related health belief and vaccination rate. J Korean Soc Matern Child Health. 2013;17:27–37. Article
5. Yoo MS. Knowledge level of human papillomavirus, cervical cancer and vaccination status among mothers with daughters in high school. Korean J Women Health Nurs. 2014;20:105–14. Article PubMed
6. Choi MS, Cheon S. HPV (human papillomavirus) vaccination coverage and intention among female middle and high school students. J Korean Soc Living Environ Syst. 2015;22:93–105. Article
7. Oh JK, Lim MK, Yun EH, Lee EH, Shin HR. Awareness of and attitude towards human papillomavirus infection and vaccination for cervical cancer prevention among adult males and females in Korea: a nationwide interview survey. Vaccine. 2010;28:1854–60. Article PubMed
8. Kim JS, Kang HY. Mothers' knowledge, health beliefs and intentions to vaccinate their daughters against human papillomavirus in Korea. Contemp Nurse. 2014;47:97–107. Article PubMed
9. Kang HY, Kim JS. Knowledge, attitudes of human papillomavirus vaccine, and intention to obtain vaccine among Korean female undergraduate students. Women Health. 2011;51:759–76. Article PubMed
10. Lee EJ, Park JS. Knowledge about cervical cancer, health beliefs and human papillomavirus vaccination rate in female university students. J Korean Oncol Nurs. 2011;11:65–73. Article
11. Korean Centers for Disease Control and Prevention. Guidelines for the National Immunization Program [Internet]. Cheongju: Korean Centers for Disease Control and Prevention; 2017. [cited 2017 Jan 6]. Available from: https://nip.cdc.go.kr
12. Graham JE, Mishra A. Global challenges of implementing human papillomavirus vaccines. Int J Equity Health. 2011;10:27.Article PubMed PMC
13. Glanz K, Rimer BK, Lewis FM. Health behavior and health education: theory, research, and practice. San Francisco, CA: Jossey-Bass; 2002.
14. Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48:436–50. Article PubMed PMC PDF
15. Jun JK, Choi KS, Jung KW, Lee HY, Gapstur SM, Park EC, et al. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study. Int J Cancer. 2009;124:188–93. Article PubMed
16. National Cancer Information Center. Cancer statistics in 2014, Korea [Internet]. Goyang: National Cancer Information Center; 2016. [cited 2016 Dec 20]. Available from: http://www.cancer.go.kr

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

An investigation into the human papilloma virus (HPV) vaccination among undergraduate medical students (A prospective cross-sectional KAP survey)
Remah M Kamel, Aseel Alomari, Abeer Ismail, Rogayah Alballa, A’laa Almowallad, Laila Alsankari, Mona Sabsabi
Obstetrics & Gynecology International Journal.2024; 15(5): 194. CrossRef
Parental Factors Affecting Decision to Vaccinate Their Daughters against Human Papillomavirus
Yoon Park, Moran Ki, Hyunju Lee, Jae-Kwan Lee, Jin-Kyoung Oh
Cancer Prevention Research.2023; 16(3): 133. CrossRef
Parental intention to vaccinate daughters with the human papillomavirus vaccine in Korea: a nationwide cross-sectional survey
Yejin Ha, Kyeongmin Lee, Bomi Park, Mina Suh, Jae Kwan Jun, Kui Son Choi
Epidemiology and Health.2023; 45: e2023076. CrossRef
ARE WOMEN AWARE OF THE VACCINE AGAINST HUMAN PAPILLOMAVIRUS? A HOSPITAL-FOCUSED CROSS-SECTIONAL STUDY
Ülkü Ayşe TÜRKER, Binali ÇATAK
SDÜ Tıp Fakültesi Dergisi.2022; 29(2): 249. CrossRef
Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005–2020
Hye Young Shin, Yun Yeong Lee, Soo Yeon Song, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
Journal of Gynecologic Oncology.2022;[Epub] CrossRef
Perception of human papilloma virus (HPV) vaccination during the COVID-19 pandemic
Ye Won Jung, Soo Youn Song, Won Kyo Shin, Su Min Chung, Ji Won Park, Heon Jong Yoo
Medicine.2022; 101(43): e31389. CrossRef
Awareness of and practice toward cancer prevention recommendations: results of the Korean National Cancer Prevention Awareness and Practice Survey in 2021
Jin-Kyoung Oh, Eunjung Park, Byungmi Kim, Yoon-Jung Choi, E Hwa Yun, Min Kyung Lim, Jeong-Soo Im, Eun Young Park
Epidemiology and Health.2022; 44: e2022068. CrossRef
The emergence of oral cavity cancer and the stabilization of oropharyngeal cancer: Recent contrasting epidemics in the South Korean population
Yuh‐Seog Jung, Jungirl Seok, Seri Hong, Chang Hwan Ryu, Junsun Ryu, Kyu‐Won Jung
Cancer.2021; 127(10): 1638. CrossRef
Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study
Jaehyun Seong, Sangmi Ryou, JeongGyu Lee, Myeongsu Yoo, Sooyoung Hur, Byeong-Sun Choi
Virology Journal.2021;[Epub] CrossRef
Factors Associated with the HPV Vaccination among Korean Americans and Koreans: A Systematic Review
Soojung Jo, Soo-Yeon Han, Connor A. Walters
International Journal of Environmental Research and Public Health.2021; 19(1): 51. CrossRef
Inequalities in Awareness and Attitude towards HPV and Its Vaccine between Local and Migrant Residents Who Participated in Cervical Cancer Screening in Shenzhen, China
Wei Lin, Yueyun Wang, Zhihua Liu, Bin Chen, Shixin Yuan, Bo Wu, Lin Gong
Cancer Research and Treatment.2020; 52(1): 207. CrossRef
Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia
Li Ping Wong, Pooi-Fong Wong, Megat Mohamad Amirul Amzar Megat Hashim, Liyuan Han, Yulan Lin, Zhijian Hu, Qinjian Zhao, Gregory D. Zimet
Human Vaccines & Immunotherapeutics.2020; 16(7): 1611. CrossRef
Chinese Residents’ Perceptions of COVID-19 During the Pandemic: Online Cross-sectional Survey Study
Tingting Cui, Guoping Yang, Lili Ji, Lin Zhu, Shiqi Zhen, Naiyang Shi, Yan Xu, Hui Jin
Journal of Medical Internet Research.2020; 22(11): e21672. CrossRef
Perceptions of nurses on human papillomavirus vaccinations in the Republic of Korea
Hae Won Kim, Hyang Yuol Lee, Seong Eun Kim, Hye Young Ahn, Yeon Hee Kim, Young Jin Lee, Italo Francesco Angelillo
PLOS ONE.2019; 14(2): e0211475. CrossRef
Current knowledge of and attitudes toward human papillomavirus‐related disease prevention among Japanese: A large‐scale questionnaire study
Yukio Suzuki, Akiko Sukegawa, Aya Nishikawa, Kazumi Kubota, Yoko Motoki, Mikiko Asai‐Sato, Yutaka Ueda, Masayuki Sekine, Takayuki Enomoto, Fumiki Hirahara, Takeharu Yamanaka, Etsuko Miyagi
Journal of Obstetrics and Gynaecology Research.2019; 45(5): 994. CrossRef
High-Risk Human Papillomavirus Infection and the Risk of Cardiovascular Disease in Korean Women
Eun-Jeong Joo, Yoosoo Chang, Min-Jung Kwon, Ara Cho, Hae Suk Cheong, Seungho Ryu
Circulation Research.2019; 124(5): 747. CrossRef
Awareness and attitude towards human papillomavirus and its vaccine among females with and without daughter(s) who participated in cervical cancer screening in Shenzhen, China
Wei Lin, Yueyun Wang, Zhihua Liu, Bin Chen, Shixin Yuan, Bo Wu, Lin Gong
Tropical Medicine & International Health.2019; 24(9): 1054. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Awareness of and Attitudes toward Human Papillomavirus Vaccination among Adults in Korea: 9-Year Changes in Nationwide Surveys

Cancer Res Treat. 2018;50(2):436-444. Published online May 10, 2017

DOI: https://doi.org/10.4143/crt.2017.174

XML Download

Top of article

Abstract
Introduction
Materials and Methods
Results
Discussion
NOTES
REFERENCES

Awareness of and Attitudes toward Human Papillomavirus Vaccination among Adults in Korea: 9-Year Changes in Nationwide Surveys

Characteristic	Survey year
Characteristic	2007	2016
Sex
Men	496 (49.6)	594 (49.5)
Women	504 (50.4)	606 (50.5)
Age (yr)
20-29	222 (22.2)	196 (16.3)
30-39	239 (23.9)	243 (20.3)
40-49	225 (22.5)	268 (22.3)
≥ 50	314 (31.4)	493 (41.1)
Education
Middle school or less	195 (19.5)	76 (6.3)
High school	459 (45.9)	502 (41.8)
College or more	345 (34.5)	622 (51.8)
Occupation
Agriculture/Forestry/Fishery	39 (3.9)	3 (0.3)
Self-employment	217 (21.7)	152 (12.7)
Clerk/Sale	117 (11.7)	205 (17.1)
Engineer/Driver	57 (5.7)	74 (6.2)
Janitor/Cleaner/Construction worker	20 (2.0)	27 (2.2)
Office worker	141 (14.1)	325 (27.1)
Professional/Manager	9 (0.9)	32 (2.7)
House wife	274 (27.4)	279 (23.2)
Student	68 (6.8)	64 (5.3)
Unemployment	58 (5.8)	39 (3.2)
Household income per month^a)
Low	232 (23.2)	236 (19.7)
Middle	562 (56.2)	685 (57.1)
High	197 (19.7)	279 (23.2)
Region
Metropolitan area	479 (47.9)	542 (45.2)
City	421 (42.1)	523 (43.6)
Country	100 (10.0)	135 (11.2)

Variable	Overall		p-value^a)	Men		p-value^a)	Women		p-value^a)
Variable	2007	2016	p-value^a)	2007	2016	p-value^a)	2007	2016	p-value^a)
[Awareness] Did you know that cervical cancer is related to HPV infection?
No	867 (86.7)	770 (64.2)		459 (92.5)	424 (71.4)		408 (80.9)	346 (57.1)
Yes	133 (13.3)	430 (35.8)	< 0.001	37 (7.5)	170 (28.6)	< 0.001	96 (19.1)	260 (42.9)	< 0.001
[Awareness] Did you know that cervical cancer can be prevented by HPV vaccination?
No	914 (91.4)	757 (63.1)		471 (95.0)	431 (72.6)		443 (87.9)	326 (53.8)
Yes	86 (8.6)	443 (36.9)	< 0.001	25 (5.0)	163 (27.4)	< 0.001	61 (12.1)	280 (46.2)	< 0.001
[Perceived susceptibility] Do you think you can be easily infected with HPV?
No	282 (28.2)	504 (42.0)		149 (30.0)	263 (44.3)		133 (26.4)	241 (39.8)
Yes	195 (19.5)	308 (25.7)		86 (17.3)	98 (16.5)		109 (21.6)	210 (34.6)
Do not know	523 (52.3)	388 (32.3)	< 0.001	261 (52.6)	233 (39.2)	< 0.001	262 (52.0)	155 (25.6)	< 0.001
[Perceived seriousness] Do you think HPV infection is a serious disease?
No	80 (8.0)	284 (23.7)		40 (8.1)	148 (24.9)		40 (7.9)	136 (22.4)
Yes	325 (32.5)	469 (39.1)		126 (25.4)	193 (32.5)		199 (39.5)	276 (45.5)
Do not know	595 (59.5)	447 (37.3)	< 0.001	330 (66.5)	253 (42.6)	< 0.001	265 (52.6)	194 (32.0)	< 0.001
[Perceived benefits] Would you be vaccinated against HPV if HPV infection is preventable?
No	167 (16.7)	348 (30.9)		71 (14.3)	175 (30.5)		96 (19.0)	173 (31.3)
Yes	550 (55.0)	291 (25.8)		275 (55.4)	144 (25.1)		275 (54.6)	147 (26.6)
Uncertain	283 (28.3)	488 (43.3)	< 0.001	150 (30.2)	255 (44.4)	< 0.001	133 (26.4)	233 (42.1)	< 0.001
[Perceived benefits] If HPV infection is preventable, would you vaccinate your daughter against HPV?
No	46 (4.6)	115 (9.6)		28 (5.6)	58 (9.8)		18 (3.6)	57 (9.4)
Yes	770 (77.0)	834 (69.5)		374 (75.4)	391 (65.8)		396 (78.6)	443 (73.1)
Already vaccinated		32 (2.7)			9 (1.5)			23 (3.8)
Will vaccinated		802 (66.8)			382 (64.3)			420 (69.3)
Uncertain	184 (18.4)	251 (20.9)	< 0.001	94 (19.0)	145 (24.4)	0.001	90 (17.9)	106 (17.5)	0.001
[Perceived benefits] If HPV infection is preventable, would you vaccinate your son against HPV for your future daughter-in-law?
No	56 (5.6)	159 (13.3)		29 (5.8)	79 (13.3)		27 (5.4)	80 (13.2)
Yes	732 (73.2)	702 (58.5)		352 (71.0)	341 (57.4)		380 (75.4)	361 (59.6)
Already vaccinated		10 (0.8)			4 (0.7)			6 (1.0)
Will vaccinated		692 (57.7)			337 (56.7)			355 (58.6)
Uncertain	212 (21.2)	339 (28.3)	< 0.001	115 (23.2)	174 (29.3)	< 0.001	97 (19.2)	165 (27.2)	< 0.001
[Awareness] Did you know that free HPV vaccination is available for girls ages 11-12 by a national immunization program in 2016?
No		995 (82.9)			522 (87.9)			473 (78.0)
Yes		205 (17.1)			72 (12.1)			133 (22.0)

Characteristic	Total	Willingness to vaccinate oneself^a)			Willingness to vaccinate daughter
		No. (%)	Adjusted OR (95% CI)		No. (%)	Adjusted OR (95% CI)
		No. (%)	Model 1^b)	Model 2^c)	No. (%)	Model 1^b)	Model 2^c)
Sex
Men	594	144 (25.1)	1	1	391 (65.8)	1	1
Women	606	147 (26.6)	1.1 (0.9-1.5)	1.1 (0.9-1.5)	443 (73.1)	1.4 (1.1-1.8)	1.5 (1.1-1.9)
Age (yr)
≥ 50	493	101 (21.3)	1	1	342 (69.4)	1	1
40-49	268	70 (27.8)	1.4 (1.0-2.0)	1.4 (1.0-2.0)	189 (70.5)	1.1 (0.8-1.5)	1.0 (0.7-1.4)
30-39	243	65 (29.3)	1.5 (1.1-2.2)	1.5 (1.0-2.2)	170 (70.0)	1.1 (0.8-1.5)	1.0 (0.7-1.4)
20-29	196	55 (30.7)	1.7 (1.1-2.4)	1.6 (1.1-2.5)	133 (67.9)	1.0 (0.7-1.4)	0.9 (0.6-1.3)
			p-trend=0.004	p-trend=0.009		p-trend=0.926	p-trend=0.637
Education
Middle school or less	76	16 (21.1)	1	1	43 (56.6)	1	1
High school	502	119 (25.1)	1.1 (0.6-2.0)	1.1 (0.6-2.0)	363 (72.3)	2.2 (1.3-3.7)	2.2 (1.3-3.7)
College or more	622	156 (27.1)	1.1 (0.6-2.0)	1.1 (0.6-2.0)	428 (68.8)	2.0 (1.2-3.3)	2.0 (1.2-3.3)
			p-trend=0.821	p-trend=0.821		p-trend=0.308	p-trend=0.308
Income per month
Low (< 3,000 USD)	236	46 (20.1)	1	1	160 (67.8)	1	1
Middle (3,000-5,000 USD)	685	168 (26.3)	1.3 (0.9-1.9)	1.4 (0.9-2.0)	469 (68.5)	1.1 (0.8-1.5)	0.9 (0.7-1.3)
High (> 5,000 USD)	279	77 (29.8)	1.6 (1.0-2.4)	1.7 (1.1-2.6)	205 (73.5)	1.3 (0.9-2.0)	1.2 (0.8-1.9)
			p-trend=0.030	p-trend=0.026		p-trend=0.126	p-trend=0.205
Region
Metropolitan area	542	135 (26.5)	1	1	376 (69.4)	1	1
Middle/Small city	523	132 (26.8)	1.0 (0.8-1.3)	1.0 (0.8-1.3)	371 (70.9)	1.1 (0.8-1.4)	1.0 (0.8-1.4)
Small town	135	24 (19.4)	0.7 (0.4-1.1)	0.7 (0.4-1.1)	87 (64.4)	0.8 (0.5-1.2)	0.7 (0.5-1.1)
			p-trend=0.306	p-trend=0.297		p-trend=0.536	p-trend=0.491
Awareness of HPV infection as a risk factor of cervical cancer
No	770	185 (24.4)	1	1	507 (65.8)	1	1
Yes	430	106 (28.7)	1.2 (0.9-1.6)	1.2 (0.9-1.6)	327 (76.1)	1.6 (1.2-2.1)	1.5 (1.2-2.0)
Awareness of HPV vaccine
No	757	173 (23.7)	1	1	493 (65.1)	1	1
Yes	443	118 (29.8)	1.3 (1.0-1.8)	1.3 (1.0-1.8)	341 (77.0)	1.8 (1.3-2.2)	1.7 (1.3-2.2)
Perceived seriousness
No	284	47 (17.5)	1	1	172 (60.6)	1	1
Yes	469	145 (33.6)	2.4 (1.6-3.4)	2.4 (1.6-3.4)	375 (80.0)	2.5 (1.8-3.5)	2.5 (1.8-3.4)
Do not know	447	99 (23.2)	1.4 (1.0-2.1)	1.4 (1.0-2.1)	287 (64.2)	1.2 (0.9-1.6)	1.2 (0.9-1.6)
Awareness on NHPVP
No	995	239 (25.1)	1	1	682 (68.5)	1	1
Yes	205	52 (29.9)	1.2 (0.8-1.7)	1.2 (0.8-1.7)	152 (74.2)	1.2 (0.9-1.8)	1.2 (0.9-1.7)

Characteristic	Total	Awareness of the National HPV Vaccination Program
		No. (%)	Adjusted OR (95% CI)
		No. (%)	Model 1^a)	Model 2^b)
Sex
Men	594	72 (12.1)	1	1
Women	606	133 (21.9)	2.1 (1.6-2.9)	2.3 (1.7-3.1)
Age (yr)
≥ 50	493	61 (12.4)	1	1
40-49	268	58 (21.6)	2.1 (1.4-3.1)	1.8 (1.2-2.7)
30-39	243	47 (19.3)	1.8 (1.2-2.7)	1.4 (0.9-2.2)
20-29	196	39 (19.9)	1.9 (1.2-3.0)	1.4 (0.9-2.3)
			p-trend=0.002	p-trend=0.130
Education
Middle school or less	76	4 (5.3)	1	1
High school	502	74 (14.7)	2.9 (1.0-8.4)	2.9 (1.0-8.4)
College or more	622	127 (20.4)	4.3 (1.5-12.5)	4.3 (1.5-12.5)
			p-trend < 0.001	p-trend < 0.001
Income per month
Low (< 3,000 USD)	236	35 (14.8)	1	1
Middle (3,000-5,000 USD)	685	119 (17.4)	1.1 (0.7-1.7)	0.9 (0.6-1.4)
High (> 5,000 USD)	279	51 (18.3)	1.2 (0.7-1.9)	0.9 (0.5-1.4)
			p-trend=0.422	p-trend=0.720
Region
Metropolitan area	542	81 (14.9)	1	1
Middle/Small city	523	103 (19.7)	1.4 (1.0-2.0)	1.4 (1.0-1.9)
Small town	135	21 (15.6)	1.0 (0.6-1.8)	1.0 (0.6-1.7)
			p-trend=0.226	p-trend=0.324
Awareness of HPV infection as a risk factor of cervical cancer
No	770	90 (11.7)	1	1
Yes	430	115 (26.7)	2.4 (1.7-3.3)	2.3 (1.7-3.2)
Awareness of HPV vaccine
No	757	73 (9.6)	1	1
Yes	443	132 (29.8)	3.6 (2.6-4.9)	3.5 (2.5-4.9)
Perceived seriousness
No	284	44 (15.5)	1	1
Yes	469	101 (21.5)	1.4 (0.9-2.1)	1.4 (0.9-2.0)
Do not know	447	60 (13.4)	0.9 (0.6-1.4)	0.9 (0.6-1.4)

Table 1. General characteristics of the respondents in the 2007 and 2016 surveys

Values are presented as number (%).

Income categorized in low (< 2,000 USD), middle (2,000-4,000 USD), and high (> 4,000 USD) in 2007; low (< 3,000 USD), middle (3,000-5,000 USD), and high (> 5,000 USD) in 2016; 1 US dollar=1,000 Korean won.

Table 2. Awareness of and attitudes toward HPV infection and vaccination: the 2007 and 2016 surveys

Values are presented as number (%). HPV, human papillomavirus.

Cochran-Mantel-Haenszel chi-square test, adjusted for age-group.

Table 3. Willingness to vaccinate oneself and respondent’s daughter(s) against HPV by selected characteristics, 2016

HPV, human papillomavirus; OR, odds ratio; CI, confidence interval; NHPVP, National HPV Vaccination Program.

The willingness to vaccinate oneself was analyzed except for 73 persons who had already received HPV vaccination before the survey,

Model 1: multiple logistic regression model adjusted for sex and age,

Model 2: multiple logistic regression model adjusted for sex, age, and education, when appropriate.

Table 4. Awareness of the national HPV vaccination program by selected characteristics, 2016

HPV, human papillomavirus; OR, odds ratio; CI, confidence interval.

Model 1: multiple logistic regression model adjusted for sex and age,

Model 2: multiple logistic regression model adjusted for sex, age and education, when appropriate.